---
title: "SELISKER RACHEL R — Ownership Dossier"
canonical: https://whiteintel.dev/entity/52fa3035-ca37-51bd-88fc-dbaa6871a378
json: https://whiteintel.dev/api/public/dossier/52fa3035-ca37-51bd-88fc-dbaa6871a378
identifier: sec:0001313793
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SELISKER RACHEL R

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001313793`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/52fa3035-ca37-51bd-88fc-dbaa6871a378  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/52fa3035-ca37-51bd-88fc-dbaa6871a378  

## Ownership & control

### Holdings / subsidiaries

- **NPS PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/3df1e359-a084-5e9c-9619-abcb1e2224dd

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SELISKER RACHEL R**. Human view: https://whiteintel.dev/entity/52fa3035-ca37-51bd-88fc-dbaa6871a378 · Structured JSON: https://whiteintel.dev/api/public/dossier/52fa3035-ca37-51bd-88fc-dbaa6871a378._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._